India: The Opportunity to be a Global Leader in Fatty Liver Disease

• India witnesses a high prevalence of metabolic-associated steatotic liver disease (MASLD), and thus holds the opportunity to be the leader.
• Education and awareness about the disease are crucial both among physicians and the public. INASL Guidance paper and CMEs for the physicians are crucial in this regard. For patient and community perspective ROCCO is crucial.
• Treatment with saroglitazar needs proper guidance for usage.
• National policies like NPCDCS should integrate nonalcoholic fatty liver disease (NAFLD).